GF Fund Management’s RAPT Therapeutics RAPT Stock Holding History

GF Fund Management’s Portfolio RAPT Stock Details RAPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-544	Closed	-$18.4K	–	651
2025 Q4	$18.4K	Buy	+544	New	+$16.9K	﹤0.01%	515

GF Fund Management's RAPT Position: Q1 2026 in Review

GF Fund Management sold out of RAPT Therapeutics (RAPT) in Q1 2026, closing a stake of 544 shares — an estimated $18.4K sold.

GF Fund Management first reported a position in RAPT in Q4 2025 and held it in 1 quarter. The position peaked at $18.4K in Q4 2025. 0 funds tracked by Wall St. Rank hold RAPT as of Q1 2026.

GF Fund Management reported no remaining RAPT Therapeutics position as of Q1 2026 after selling out during the quarter.
GF Fund Management sold 544 RAPT Therapeutics shares in Q1 2026, an estimated $18.4K.
GF Fund Management first reported a position in RAPT Therapeutics in Q4 2025 and held it in 1 quarter.
GF Fund Management's RAPT Therapeutics position peaked at $18.4K in Q4 2025.
0 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q1 2026.

Based on GF Fund Management's 13F filing for Q1 2026, filed 15 Apr 2026.